Strains of Proteus penneri from seven abdominal wounds (after bowel resection), five urine samples, and eight other sites were isolated in mixed cultures. Seven urine isolates were in pure cultures. All infections were nosocomially acquired, indicating that complete identification of P. penneri in the clinical laboratory is warranted.
In 1982, the name Proteus penneri sp. nov. was proposed for a group of bacteria previously known as Proteus vulgaris indole negative or P. vulgaris biogroup 1 (2) . The authors had only 20 strains, for which there was little information on clinical significance. This prompted laboratories to examine isolates of the species to determine more precisely their susceptibilities to antibiotics, their biochemical reactions, and their particular role in human infections (1, 4, 6, 7) . In addition to their resistance to chloramphenicol, a species characteristic (2), they have been found typically resistant to cefazolin and cefsulodin; a few strains are also resistant to amikacin, piperacillin, and cefoperazone (1) . Most strains are susceptible to cefotaxime and ceftriaxone, and all strains tested have been found highly susceptible to ceftizoxime, ceftazidime, moxalactam, cefoxitin, gentamicin, tobramycin, and netilmicin (1) . An interesting observation in one study (6) was that all P. penneri and 26% of the Proteus mirabilis isolates produced a green color reaction with Kovacs reagent, indicating that tryptophan is metabolized by these bacteria in a manner different from that of the indole-positive members of the tribe Proteeae.
Examination of the literature for reports on indolenegative P. vulgaris before 1982 indicated that the species occurred in human specimens but was not given special attention apart from its negative reaction in the test for indole production (3, 5, 8) . The first reported case of an infection attributed to P. penneri implicated the bacterium as a pathogen of the urinary tract and suggested a role for it in the formation of struvite stones (4) . Its presence in stools has been observed, but there was no evidence to suggest it was * Corresponding author. a causative agent of diarrhea (7) . In the present report, we describe isolations of P. penneri, not only from urine but also from wounds and various other sites, indicating an extended clinical spectrum of infections.
Isolates were differentiated from other Proteus species on the basis of biochemical reactions cited as characteristic of the species (2). These included negative reactions for indole production at 48 h, negative reactions for acid production from salicin and esculin, and resistance to chloramphenicol. It should be noted that commercially prepared kits for identification of gram-negative bacteria generally do not include materials for performing some or all of these tests.
All infections occurred over a 2-year period in two acutecare hospitals in Toronto. The infections were all nosocomially acquired, and there was no evidence to suggest cross infections. Altogether, 13 isolates were from 12 females and 14 isolates were from 14 males ( Table 1. ). The most frequent source was urine, and 7 of the 12 strains from urine samples were isolated in pure cultures. The abdominal wound, after bowel resection, was the next most frequent source, but isolates were also obtained from eight other sites. The patient age range was from 2 to 84 years. Except for the infection in the 2-year-old, the range was from 54 to 84 years, with a mean of 71.7 years. The occurrence of P. penneri organisms in the normal intestine (7) accounts for their higher frequency in urinary tract infections and for their role as opportunistic invaders after surgery. In fact, P. penneri was isolated from 11 of the 26 participating patients (42.3%) after abdominal or other surgery.
Although the number of cases in this study is limited, it is clear that P. penneri is yet another agent capable of causing nosocomial disease and thus warrants complete identification and speciation in the clinical laboratory, even though this entails performing some biochemical tests in addition to those routinely used for members of the family Enterobacteriaceae.
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